BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of nitric oxide
,
Rosiglitazone
,
rs2230926
,
BRAF
,
Lung cancer
,
Embryo
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
L -dopa
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Hodgkin Reed-Sternberg cell lines KM-H2, L-428, L-540, L-1236, and HDLM-2
Hodgkin's lymphoma L-428 and L-1236 cells treated with decitabine (5-Aza-dC)
Explore Curated Studies Results
Literature
Most Relevant Literature
Machine-learning model for the prediction of acute orthostatic hypotension after levodopa administra…
Eumelanin-like Poly(levodopa) Nanoscavengers for Inflammation Disease Therapy.
Physicochemically modulated fluorescence-scattering ratiometric sensor for selective and visual dete…
L-Dopa in small peptides: an amazing functionality to form supramolecular materials.
Levodopa-induced orthostatic hypotension in parkinsonism: A red flag of autonomic failure.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Antipsychotic Augmentation With L-Dopa
Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Pa…
A Study of L-DOPA for Depression and Slowing in Older Adults
Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients…
Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ